Miki Shirakawa Garcia

100% Complete response rate in patients with cutaneous metastatic melanoma treated with intralesional interleukin (IL)-2, imiquimod, and topical retinoid combination therapy: Results of a case series

Vivian Y. Shi, Khiem A. Tran, Forum Patel et al. · Journal of the American Academy of Dermatology · 2015 · 52 citations · Full text

Medicine, Dermatology, Oncology +17

A Pilot Study of Etanercept Treatment for Pemphigus Vulgaris

David Fiorentino, Miki Shirakawa Garcia, Wingfield Rehmus et al. · Archives of Dermatology · 2010 · 48 citations

Life Sciences, Dermatology, Pharmacotherapy +17

Treatment of Dermatosis Papulosa Nigra in 10 Patients: A Comparison Trial of Electrodesiccation, Pulsed Dye Laser, and Curettage

Miki Shirakawa Garcia, Rahman Azari, Daniel B. Eisen · Dermatologic Surgery · 2010 · 35 citations

Medicine, Dermatology, Surgery +14

Complete regression of subcutaneous and cutaneous metastatic melanoma with high-dose intralesional interleukin 2 in combination with topical imiquimod and retinoid cream

Miki Shirakawa Garcia, Yoko Ono, Steve R. Martinez et al. · Melanoma Research · 2011 · 34 citations

Medicine, Dermatology, Oncology +17

Hyperpigmented burn scar improved with a fractionated 1550 nm non-ablative laser

Daniel Q. Bach, Miki Shirakawa Garcia, Daniel B. Eisen · Dermatology Online Journal · 2012 · 16 citations · Full text

Medicine, Dermatology, Surgery +17